The Bridge Device was granted a new indication by the FDA for use in helping reduce the symptoms of opioid withdrawal.
The Bridge Device was cleared by the FDA and categorized as a neurology device. The Bridge is the first non-pharmaceutical, non-implantable medical device available today for opiate (heroin) and opioid (e.g. oxycontin, methadone, suboxone) addicts needing help with withdrawal pain and associated symptoms.
The product is available today (by prescription only) from one of our trained providers at a cost of $1,200 for the device plus the cost of the provider to administer the device. At date of posting, the device is NOT covered by any insurance carriers but we are close to making this a reality with several Medicaid States and some major PPO providers.
The Bridge Device combines the latest cutting-edge micro technology with IHS propriety software in a biocompatible housing that fits discretely behind the ear. The Bridge is a percutaneous nerve field stimulator that has been FDA Cleared for use as an aid for reducing symptoms of opioid withdrawal through application to branches of cranial nerves 5, 7, 9, 10 and the occipital nerves identified by transillumination.
University based research studies indicate The Bridge sends gentle electrical impulses to areas of the brain and branches of nerves leading to the spinal cord via percutaneously implanted electrodes near nerve endings found in and around the ear. Effectively aiding in the reduction of symptoms of opioid withdrawal often as little as 10 minutes.